News - Vaccines

Filter

Current filters:

Vaccines

Popular Filters

226 to 250 of 260 results

First US cell-based flu vaccine plant

13-12-2011

Under a public-private partnership of the US Department of Health and Human Services and Novartis Vaccines…

Markets & MarketingNorth AmericaNovartisPharmaceuticalVaccines

Takeda to establish dedicated vaccine business division

06-12-2011

Japan’s largest drugmaker, Takeda Pharmaceutical (TYO: 4502), says it plans to establish a Vaccine…

ManagementPharmaceuticalResearchTakeda PharmaceuticalsVaccines

New global data on influenza vaccine provision and level of support for immunization policies

28-11-2011

The findings of two studies being published this week in peer-reviewed journals look at global vaccination…

GlobalHealthcarePharmaceuticalRespiratory and PulmonaryVaccines

Stronger incentives for immunization of children in Australia

28-11-2011

Australia’s childhood immunization arrangements are to be reformed with the aim of increasing the…

Asia-PacificFinancialHealthcarePharmaceuticalVaccines

Indian vaccine market targets $4.6 billion revenue by 2017, up from current $900 million

17-11-2011

The Indian vaccine market is currently estimated to be worth around $900 million and targets $4.6 billion…

Asia-PacificMarkets & MarketingPharmaceuticalResearchVaccines

Transgene to seek partner for HCV vaccine TG4040 on strong Ph II results

09-11-2011

French biotech firm Transgene (Euronext Paris: FR0005175080) has revealed interim data showing a substantial…

BiotechnologyLicensingOncologyPharmaceuticalResearchTransgeneVaccines

Hepatitis B vaccines market forecast to show moderate growth until 2018

03-11-2011

The global hepatitis B vaccines market is estimated to be worth $997.0 million in 2010, and is forecast…

Anti-viralsGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalVaccines

Russia’s RusNano invests in Selecta and BIND to develop and commercialize vaccines and cancer drugs

30-10-2011

Two USA-based nano-medicines companies, BIND Biosciences and Selecta Biosciences, have entered into investment…

BIND BiosciencesBiotechnologyFinancialOncologyResearchRusNanoSelecta BiosciencesVaccines

Activartis develops dendritic cell-based cancer vaccine in Ph II; will seek partner

27-10-2011

Privately-held Austrian company Activartis GmbH (formerly Trimed Biotech) is developing a cancer immunotherapy…

ActivartisLicensingOncologyPharmaceuticalResearchVaccines

Gilead collaborates with GlobeImmune to develop vaccine for chronic hepatitis B infection

25-10-2011

Gilead Sciences (Nasdaq: GILD) has entered into an exclusive worldwide license and collaboration agreement…

Anti-viralsBiotechnologyGilead SciencesGlobeImmuneLicensingResearchVaccines

Cancer vaccines market set to see change, will grow to over $9 billion by 2018

24-10-2011

The global cancer vaccines market in seven key markets (the USA, France, Germany, Italy, Spain, UK and…

CervarixDendreonGardasilGlaxoSmithKlineGlobalMarkets & MarketingMerck & CoOncologyPharmaceuticalProvengeVaccines

GlaxoSmithKline warned by US FDA over cGMP violations at UK plant; positive malaria vaccine news

20-10-2011

UK pharma giant GlaxoSmithKline ILSE: GSK) has received a warning letter from the US Food and Drug Administration…

Antibiotics and Infectious diseasesGlaxoSmithKlinePharmaceuticalRegulationResearchVaccines

Sinovac awarded contract to supply Anflu flu vaccine to Beijing CDC

16-10-2011

Chinese biopharmaceuticals company Sinovac Biotech (Nasdaq: SVA) saw its share price jump 12% to $2.49…

AnfluAsia-PacificBiotechnologyMarkets & MarketingSinovacVaccines

Scripps scientists’ findings could advance AIDS vaccine development

16-10-2011

Researchers at the USA-based Scripps Research Institute have uncovered the surprising details of how…

Anti-viralsPharmaceuticalResearchVaccines

Global vaccines market to be worth $20.8 billion in 2015, says Visiongain

11-10-2011

The worldwide vaccines market will reach a value of $20.8 billion in 2015, nearly double the $10.7 billion…

GlobalMarkets & MarketingPharmaceuticalVaccines

Biotron shares leap 29% on hepatitis C Ph IIa positive results; Inovio advances hepatitis vaccines

11-10-2011

Australian firm Biotron (ASX: BIT) has received some strong support in the first couple of hours of market…

Anti-viralsBiotronInovio PharmaceuticalsLicensingPharmaceuticalResearchVaccinesVGX International

Sanofi oral MS drug Aubagio shows strong efficacy in Ph III trial; plans massive Indian vaccine plant

07-10-2011

French drug major Sanofi (Euronext: SAN) and its subsidiary Genzyme says that the results of a pivotal…

Asia-PacificAubagioFinancialGenzymeNeurologicalPharmaceuticalResearchSanofiShanthaVaccines

Emergent BioSolutions gets $1.25 billion BioThrax order for US government

04-10-2011

Emergent BioSolutions (NYSE: EBS) revealed yesterday that it has received an award to supply the US government…

BioThraxEmergent BioSolutionsFinancialMarkets & MarketingNorth AmericaPharmaceuticalVaccines

Cost benefit analysis of cervical cancer vaccines sees Gardasil beat Cervarix

29-09-2011

An analysis of cervical-cancer vaccine has shown that Merck & Co’s (NYSE: MRK) Gardasil (human papillomavirus…

CervarixEuropeGardasilGlaxoSmithKlineMerck & CoPharmaceuticalPricingVaccines

GAVI Alliance delivers on its promise to tackle diarrhea and pneumonia

29-09-2011

The GAVI Alliance announced this week that it will provide funding for 16 more developing countries to…

GlobalHealthcarePharmaceuticalVaccines

Daiichi Sankyo admits supply problem with flu vaccine; gains approval for silodosin in China

23-09-2011

Japanese drug major Daiichi Sankyo (TYO: 4568) announced this week that its domestic subsidiary, Kitasato…

Asia-PacificDaiichi SankyoMarkets & MarketingOncologyPharmaceuticalRegulationsilodosinVaccines

226 to 250 of 260 results

Back to top